Top Ten 2022: Provider M&A Faces New Antitrust Headwinds
- January 14, 2022
Based on AHLA’s annual Health Law Connections article, this special series brings together thought leaders from across the health law field to discuss the top ten issues of 2022. In the second episode, Michael Ramey, Principal, PYA, speaks with Lisl Dunlop, Partner, Axinn, about the shifting dynamics in federal antitrust enforcement under the Biden Administration. They discuss new factors that the government is considering related to enforcement, the dynamics between federal and state enforcement efforts, the potential for increased review of prior consummated transactions, and the consequences of a “Whole-of-Government Competition Policy” approach. Sponsored by PYA.
You must be logged in to access this content.